MUSTANG BIO, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mustang Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q4 2024.
  • Mustang Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$952K, a 89% increase year-over-year.
  • Mustang Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$15.8M, a 69.5% increase year-over-year.
  • Mustang Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$15.8M, a 69.5% increase from 2023.
  • Mustang Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$51.6M, a 33.4% increase from 2022.
  • Mustang Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$77.5M, a 16.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 -$952K +$7.66M +89% Dec 31, 2024 10-K 2025-03-28
Q3 2024 -$1.41M +$8.65M +86% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$8.2M +$8.04M +49.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$5.19M +$11.5M +68.9% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$8.62M +$11M +56.1% Dec 31, 2023 10-K 2025-03-28
Q3 2023 -$10.1M +$8.94M +47.1% Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$16.2M +$2.86M +15% Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$16.7M +$3.1M +15.7% Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19.6M +$415K +2.07% Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$19M -$1.99M -11.7% Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$19.1M -$4.74M -33% Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$19.8M -$4.84M -32.3% Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$20M +$559K +2.71% Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$17M -$4.05M -31.3% Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$14.4M +$239K +1.64% Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$15M -$3.1M -26.1% Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$20.6M -$4.4M -27.1% Dec 31, 2020 10-K 2022-03-23
Q3 2020 -$13M -$2.78M -27.4% Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$14.6M -$4.2M -40.4% Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$11.9M -$2.24M -23.3% Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$16.2M -$4.44M -37.7% Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$10.2M -$2.65M -35.2% Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$10.4M -$5.31M -104% Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$9.61M -$3.33M -53% Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$11.8M +$3.83M +24.6% Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$7.52M -$578K -8.33% Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$5.09M +$436K +7.89% Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$6.28M -$3.06M -95.2% Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$15.6M -$6.85M -78.3% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$6.94M -$5.07M -271% Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$5.53M -$4.4M -388% Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$3.22M -$2.32M -256% Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$8.75M -$7.84M -860% Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$1.87M -$1.15M -161% Sep 30, 2016 10-K 2018-03-29
Q2 2016 -$1.13M -$554K -95.7% Jun 30, 2016 10-K 2018-03-29
Q1 2016 -$903K +$1.36M +60% Mar 31, 2016 10-K 2018-03-29
Q4 2015 -$911K Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$716K Sep 30, 2015 10-K 2017-03-31
Q2 2015 -$579K Jun 30, 2015 10-K 2017-03-31
Q1 2015 -$2.26M Mar 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.